ICO KYC Report
2 members invited
About Cannacor
Whitepaper
Missing whitepaper? Let us know.
Ratings
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Clemen Chiang
Ph.D. | CEO | FinTech in Stocks | Blockchain in Cryptos | Author of Amazon Best Sellers in Online Trading
Rated on Oct 30, 2019
Rated on Oct 30, 2019
1
1
1
31%
Even though KYC does not guarantee ICO success nor is a call for investment, the process verifies the key members of the founding team as a first key test.
Please contact Sum & Substance promptly since your ICO starts in 46 days! One team member has FAILED the KYC?
Willing to revise this rating if the team responds.
All the best!
Agree
0
Disagree
ReportExperts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
Press Releases
Blog
Team
Apply as an advisorFinancial
Token info
Token
CANO
Platform
Ethereum
Type
ERC20
PreICO price
1 CANO = 0.06 USD
Price in ICO
0.1200 USD
Tokens for sale
409,500,000
Investment info
Accepting
ETH, BTC, XRP
Distributed in ICO
78%
Soft cap
1,500,000 USD
Hard cap
110,565,000 USD
Milestones
1
Q4 2018
Research and brainstorm sessions initiated to establish most viable
solution to cultivate medical cannabis
Current technologies researched to establish the CannaCor
cryptocurrency
Various blockchain technologies researched to manage the medical
cannabis cultivation life cycle and supply chain management systems
Strategic alliances formed with blockchain developers, cultivators
and pioneers in the cannabis industry
Company incorporated in Lesotho, southern Africa, to operate the
following business activities:
- growing of drug and pharmaceutical crops
- wholesale and/or retail sale of pharmaceutical and medical goods.
2
Q1 2019
50 000 m2 agricultural land acquired in Lesotho, southern Africa, for
the cultivation of medical cannabis
Environmental Impact Assessment (EIA) curated and submitted
Licence application lodged with the Drug Control Authorities in
Lesotho to obtain:
- authorization for export and import of medical cannabis
- authorization to produce medical cannabis products
3
Q2 2019
Blockchain developer and ICO marketing team appointed
Greenpaper development
Design of cannabis cultivation plant.
4
Q3 2019
CannaCor medical cannabis cultivation licence approved
New website design / landing page
Wallets and user administration panel development
Greenpaper updated and new corporate identity incorporated
Pre-ICO round starts 11 September 2019 and ends 15 December
2019.
5
Q4 2019
- Design of cultivation plant, testing laboratory and packaging plant
finalised
-Construction of cultivation facility
- Blockchain and Hyperledger Fabric application development,
incorporating QR code labelling, product traceability, drug
authentication, production life cycle management and supply chain
applications
- New wallets and website release.
6
Q1 2020
- CannaCor application BETA testing
- First cannabis crops planted
- Application integration of production cycles
7
Q2 2020
First harvest, application integration of supply chain and first coin
buy-back.
